EMEA-000026-PIP02-11
Key facts
| Invented name |
Torisel
|
| Active substance |
Temsirolimus
|
| Therapeutic area |
Oncology
|
| Decision number |
P/262/2011
|
| PIP number |
EMEA-000026-PIP02-11
|
| Pharmaceutical form(s) |
Concentrate and diluent for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of mantle cell lymphoma
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Pfizer Limited
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|